Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
- Status
- TERMINATED
- Phase
- PHASE3
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans
- Status
- COMPLETED
- Phase
- N/A
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2